注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   VEGF R1/FLT-1   

VEGF R1/FLT-1

     
  • 产品详情
  • 实验流程
Product Information
Primary Accession P17948-1
Species Human
Sequence Ser27-Asn756
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per µg by the LAL method.
Biological Activity Immobilized Human VEGF165 at 1 µg/ml (100 µl/Well) on the plate can bind VEGF R1/FLT-1[Biotin], His&Avi, Human (Cat.No.: Z03969)
Expression System HEK293
Theoretical Molecular Weight 85.1 kDa
Formulation Lyophilized from a 0.22 µm filtered solution in PBS, (pH 7.4).
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 µg/ml.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.
Additional Information
Target Background Vascular endothelial growth factor receptor 1(VEGFR1), also known as Flt-1, is a type I transmembrane glycoprotein of receptor tyrosine kinases (RTKs) family. VEGFR1 acts as a cell-surface receptor for VEGFA, VEGFB and PGF. It plays an important role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration and cancer cell invasion.
Protein Information
Research Areas

For Research Use Only. Not For Use In Diagnostic Procedures.

FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价